Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mBio
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Research Article | Host-Microbe Biology

The Immune Protein Calprotectin Impacts Clostridioides difficile Metabolism through Zinc Limitation

Christopher A. Lopez, William N. Beavers, Andy Weiss, Reece J. Knippel, Joseph P. Zackular, Walter Chazin, Eric P. Skaar
Robert A. Britton, Invited Editor, Kimberly A. Kline, Editor
Christopher A. Lopez
aDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
bVanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William N. Beavers
aDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
bVanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andy Weiss
aDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
bVanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reece J. Knippel
aDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
bVanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph P. Zackular
cDepartment of Pathology and Laboratory Medicine, Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
gDivision of Protective Immunity, Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter Chazin
dDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee, USA
eDepartment of Biochemistry, Vanderbilt University, Nashville, Tennessee, USA
fCenter for Structural Biology, Vanderbilt University, Nashville, Tennessee, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric P. Skaar
aDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
bVanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert A. Britton
Baylor College of Medicine
Roles: Invited Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kimberly A. Kline
Nanyang Technological University
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mBio.02289-19
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Supplemental Material
  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    C. difficile alters gene transcription in response to CP treatment and infection. (A) Combined RNA-seq and Nanostring results showing global changes in C. difficile gene expression in response to CP in medium and significantly different changes in gene expression during infection compared to that in medium, respectively. (i and ii) Sense and antisense genes, respectively, in C. difficile strain R20291. (iii and iv) Each bar represents a gene significantly upregulated or downregulated, respectively, in medium containing calprotectin compared to that in medium alone. Each level of color gradation represents a 2.5-fold change. Genes with expression > or <7.5-fold change are represented with bars that hit the maximum limit. (v) Green bars show phage genes present in RNA-seq. (vi and vii) Each bar represents genes from Nanostring panel with significantly upregulated or downregulated expression, respectively, during infection relative to expression in medium. (B) Genes identified in the RNA-seq analysis with significantly different expression grouped into predicted functional categories. (C) Log2 fold change of genes from the Nanostring panel significantly upregulated or downregulated during infection compared to expression in medium. #, genes similarly upregulated or downregulated in RNA-seq and Nanostring panel; ^, gene with expression found to be significantly upregulated according to RNA-seq in response to calprotectin but significantly downregulated according to Nanostring during infection.

  • FIG 2
    • Open in new tab
    • Download powerpoint
    FIG 2

    Calprotectin-mediated Zn limitation leads to increased expression of proline fermentation genes. (A) Relative prdA expression normalized to rpoB via qPCR in TY medium with or without 30 mM l-proline, 42 μM or 150 μM ZnCl2, 42 μM MnCl2, calprotectin site I mutant (CP ΔSI), or site I and site II (CP ΔSI/SII) mutant. (B) Relative prdA expression normalized to rpoB via qPCR in TY medium with or without 30 mM l-proline, 75 μM TPEN, or 75 μM ZnCl2. *, P < 0.05 one-way ANOVA followed by Tukey’s multiple-comparison test; ns, not significant.

  • FIG 3
    • Open in new tab
    • Download powerpoint
    FIG 3

    Proline fermentation contributes to C. difficile growth in vitro. (A) Genes involved in proline fermentation. Dark triangles indicate location of intron insertion using ClosTron mutagenesis. Arrow indicates the location of the selenocysteine codon in the gene of the main catalytic subunit for the proline reductase, prdB. (B) Growth of WT, prdB::CT, and prdR::CT strains in TY medium containing 30 mM l-proline as measured by OD600. (C) 5-Aminovalerate concentrations in spent media of WT C. difficile, prdB::CT, and prdR::CT strains. Error bars indicate standard deviations. nd, not detected; *, P < 0.05 between WT and prdB::CT at indicated time point; **, P < 0.05 between WT and prdR::CT at indicated time point by two-way ANOVA and Dunnett’s multiple comparisons.

  • FIG 4
    • Open in new tab
    • Download powerpoint
    FIG 4

    Proline fermentation contributes to C. difficile growth during primary and relapse infection. (A) Model of antibiotic-induced CDI and relapse. (B and C) C. difficile abundances in the feces of mice coinfected with WT C. difficile and the prdB::CT or prdR::CT mutant, respectively. Each dot represents CFU from an individual mouse. Shaded boxes represent the times when mice were provided vancomycin to induce relapse. Bars represent geometric means. (D and E) The competitive indices (CIs) (input/output ratios) of WT to mutant C. difficile in mice included in data shown in panels B and C. Each dot represents the CI for an individual mouse. Bars represent the geometric means. (F) 5-Aminovalerate concentrations in the feces of naive mice, mice provided cefoperazone treatment only, or mice provided cefoperazone treatment and subsequently infected with either WT C. difficile or the prdB::CT mutant. *, P < 0.05 by unpaired t test.

  • FIG 5
    • Open in new tab
    • Download powerpoint
    FIG 5

    Se and Zn limitation decrease C. difficile proline fermentation. (A) 5-Aminovalerate concentrations in spent medium of C. difficile grown in the presence of 75 μM TPEN. TY was supplemented with l-proline (30 mM final concentration). Each dot represents a single replicate. Bacteria were grown to early exponential phase (OD600 of ∼0.2) (B) The intracellular NAD+/NADH ratios of WT or prdB::CT C. difficile grown in TY medium with or without 75 μM TPEN or 75 μM ZnCl2. (C) Intracellular selenium abundance in C. difficile grown in TY medium with or without 75 μM TPEN or 10 μM Na2SeO3 determined through ICP-MS. (D) 5-Aminovalerate concentrations in spent medium from C. difficile grown in TY medium with or without 75 μM TPEN, 10 μM Na2SeO3, or 75 μM ZnCl2 at the indicated time points. Error bars indicate standard deviations. (E) PrdB peptide (TAVIVQR) abundance relative to abundance of an SlpA S-layer peptide (LYNLVNTQLDK). The PrdB peptide is downstream of the selenocysteine residue. Data represent 2 to 3 replicates. Error bars indicate standard deviations. *, P < 0.05 by unpaired t test.

  • FIG 6
    • Open in new tab
    • Download powerpoint
    FIG 6

    Calprotectin restricts C. difficile proline fermentation during infection. (A) Abundance of Zn and Se in the feces of WT C57BL/6 or S100A9−/− mice infected with WT C. difficile. Box plots represent the median, maximum, and minimum values; N = 8 to 10 mice per time point per genotype. (B) C. difficile abundance in coinfected mice at day 2 postinfection. Each dot represents CFU from a single mouse. *, P < 0.05, ln-transformed data. (C) The competitive indices of WT C57BL/6 and S100A9−/− mice coinfected with WT and prdB::CT C. difficile included in the data shown in panel B. *, P < 0.05 by unpaired t test; error bars represent the standard errors of the means.

Tables

  • Figures
  • Supplemental Material
  • TABLE 1

    Bacterial strains and plasmids used in this study

    TABLE 1
  • TABLE 2

    Oligonucleotide sequences used in this study

    TABLE 2
    • ↵a Boldface font indicates region in primer with sequence similarity to C. difficile.

Supplemental Material

  • Figures
  • Tables
  • TABLE S1

    C. difficile genes with significantly different expression when treated with calprotectin. Results from RNA sequencing comparing C. difficile gene expression of bacteria treated with 0.35 mg/ml CP compared to that in medium only. Download Table S1, XLSX file, 0.1 MB.

    Copyright © 2019 Lopez et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

  • TABLE S2

    Target genes and sequences from Nanostring panel. Download Table S2, XLSX file, 0.1 MB.

    Copyright © 2019 Lopez et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

  • FIG S1

    Iron chelation does not increase prdA transcription. Relative prdA expression normalized to that of rpoB via qPCR in TY medium with or without 30 mM l-proline or 50 μM 2,2-dipyridyl. *, P < 0.05 by unpaired t test. Download FIG S1, TIF file, 0.7 MB.

    Copyright © 2019 Lopez et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

  • FIG S2

    TPEN treatment and Se supplementation do not change PrdR abundance. PrdR peptide (NIGILPVLR) abundance relative to abundance of an SlpA S-layer peptide (LYNLVNTQLDK). Data presented on similar scale as shown in Fig. 5E. Data represent 2 to 3 replicates. Download FIG S2, TIF file, 0.6 MB.

    Copyright © 2019 Lopez et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

PreviousNext
Back to top
Download PDF
Citation Tools
The Immune Protein Calprotectin Impacts Clostridioides difficile Metabolism through Zinc Limitation
Christopher A. Lopez, William N. Beavers, Andy Weiss, Reece J. Knippel, Joseph P. Zackular, Walter Chazin, Eric P. Skaar
mBio Nov 2019, 10 (6) e02289-19; DOI: 10.1128/mBio.02289-19

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mBio article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Immune Protein Calprotectin Impacts Clostridioides difficile Metabolism through Zinc Limitation
(Your Name) has forwarded a page to you from mBio
(Your Name) thought you would be interested in this article in mBio.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Immune Protein Calprotectin Impacts Clostridioides difficile Metabolism through Zinc Limitation
Christopher A. Lopez, William N. Beavers, Andy Weiss, Reece J. Knippel, Joseph P. Zackular, Walter Chazin, Eric P. Skaar
mBio Nov 2019, 10 (6) e02289-19; DOI: 10.1128/mBio.02289-19
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Clostridioides difficile
Stickland fermentation
calprotectin
proline
zinc

Related Articles

Cited By...

About

  • About mBio
  • Editor in Chief
  • Board of Editors
  • AAM Fellows
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Article Types
  • Ethics
  • Contact Us

Follow #mBio

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2150-7511